Literature DB >> 12819522

Tuberculosis risk varies with the duration of HIV infection: a prospective study of European drug users with known date of HIV seroconversion.

Liselotte van Asten1, Miranda Langendam, Robert Zangerle, Ildefonso Hernández Aguado, Faroudy Boufassa, Veronique Schiffer, Raymond P Brettle, J Roy Robertson, Arnaud Fontanet, Roel A Coutinho, Maria Prins.   

Abstract

BACKGROUND: It is not known whether the risk of active tuberculosis disease varies with the length of time that individuals are infected with HIV.
OBJECTIVE: To study how, independently of CD4 T cell count, the risk of tuberculosis varies with the duration of HIV infection.
METHODS: Using Poisson regression analysis, the incidence of and risk factors for tuberculosis were studied in 683 injecting drug users (IDU) with a documented date of HIV seroconversion followed in seven cohorts in six European countries until 1998.
RESULTS: Overall incidence was 11.5/1000 person-years. Adjusted for CD4 T cell count and geographic region, the risk ratio (RR) for tuberculosis (both pulmonary and extrapulmonary), compared with the first 3 years of HIV infection, was 2.8 for years 4 to 6 of HIV infection [95% confidence interval (CI), 1.3-6.3], 1.2 for year 7 to 9 (95% CI, 0.3-4.2) and 4.6 after 9 years (95% CI, 1.4-15.0). The adjusted RR for geographic region was 13.1 (95% CI, 4.3-40.0) for Amsterdam and 15.8 (95% CI, 4.8-52.0) for the Valencian region of Spain compared with all other sites combined.
CONCLUSION: The risk of tuberculosis is increased relatively early in HIV infection (year 4 to 6) and also later (after year 9) with possibly a relatively silent period between. As expected, IDU in Southern Europe have a substantially higher risk of tuberculosis than IDU in Northern and Central Europe. Amsterdam forms an exception for Northern Europe, with very high incidence rates.

Entities:  

Mesh:

Year:  2003        PMID: 12819522     DOI: 10.1097/00002030-200305230-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Platelets Regulate Pulmonary Inflammation and Tissue Destruction in Tuberculosis.

Authors:  Katharine A Fox; Daniela E Kirwan; Ashley M Whittington; Nitya Krishnan; Brian D Robertson; Robert H Gilman; José W López; Shivani Singh; Joanna C Porter; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

2.  Tuberculosis among drug users and homeless persons: impact of voluntary X-ray investigation on active case finding.

Authors:  U Goetsch; O K Bellinger; K-L Buettel; R Gottschalk
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

Review 3.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

4.  Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test.

Authors:  Hsin-Yun Sun; Po-Ren Hsueh; Wen-Chun Liu; Yi-Ching Su; Sui-Yuan Chang; Chien-Ching Hung; Shan-Chwen Chang
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

5.  The changing epidemiology of tuberculosis in a Spanish tertiary hospital (1995-2013).

Authors:  Andrés González-García; Jesús Fortún; Enrique Elorza Navas; Pilar Martín-Dávila; Marta Tato; Enrique Gómez-Mampaso; Santiago Moreno
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

6.  Prevalence and incidence rate of tuberculosis among HIV-infected patients enrolled in HIV care, treatment, and support program in mainland Tanzania.

Authors:  M Majigo; G Somi; A Joachim; J Manyahi; J Nondi; V Sambu; A Rwebembera; N Makyao; A Ramadhani; W Maokola; J Todd; M I Matee
Journal:  Trop Med Health       Date:  2020-09-04

7.  The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.

Authors:  Tendesayi Kufa; Violet Chihota; Victor Mngomezulu; Salome Charalambous; Suzanne Verver; Gavin Churchyard; Martien Borgdorff
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

8.  Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru.

Authors:  Eduardo Ticona; Luz Huaroto; Daniela E Kirwan; Milagros Chumpitaz; César V Munayco; Mónica Maguiña; Marco A Tovar; Carlton A Evans; Roderick Escombe; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-09-12       Impact factor: 2.345

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.